AI insider acquires 28,628-optioned shares; $19.16 strike
Rhea-AI Filing Summary
Alan S. Murray, a director of C3.ai, Inc. (AI), reported acquiring a stock option to purchase 28,628 shares of Class A common stock with an exercise price of $19.16 on 10/03/2025. The option was reported as an acquisition and shows 28,628 shares underlying the option with a stated exercisability/expiration entry of 10/02/2035. Vesting is time- and attendance-based: starting on the Vesting Commencement Date of 10/03/2025, 12.5% of the optioned shares vest at the end of each fiscal quarter while the reporting director attends regularly scheduled quarterly board meetings, through a two-year period. Any quarterly vesting missed for lack of attendance becomes suspended and will only vest after the second anniversary if attendance requirements are later met. The form is signed by an attorney-in-fact on 10/07/2025.
Positive
- Director alignment: Acquisition of 28,628 optioned shares at $19.16 aligns a director’s financial interests with shareholders
- Retention design: Quarterly vesting over two years (12.5% per quarter) encourages continued board service
Negative
- Conditional vesting: Vesting is suspended if the director misses regularly scheduled board meetings, potentially delaying ownership
- Execution timeline uncertainty: Though exercisable reference shows 10/02/2035, actual timing of conversion depends on attendance and vesting conditions
Insights
Director option grant ties compensation to continued board attendance and tenure.
The option award of $19.16 for 28,628 underlying shares is structured with quarterly vesting over two years, and vesting is explicitly conditioned on attending regularly scheduled board meetings. This design links equity realization to active governance participation rather than only to time served.
That structure reduces immediate dilution risk by delaying full vesting and creates a clear behavioral condition: missed meetings suspend quarterly vesting until after the two-year mark if attendance resumes. Investors can monitor vesting progress across the next two years for potential changes in outstanding beneficial ownership.
The grant mixes retention and performance-by-attendance features with a ten-year contractual term.
The option shows an exercise/exercisability reference of 10/02/2035, indicating a long potential term for exercise after vesting, while vesting occurs in 12.5% quarterly installments subject to attendance. This creates retention incentives and aligns a director's financial interest with ongoing board participation.
Material monitoring items include the director's actual board attendance records and any future amendments to the vesting schedule; changes would affect when the reported 28,628 shares could convert to exercised, taxable holdings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,628 | $0.00 | -- |
Footnotes (1)
- [object Object]
